Recognition Resolution (Resolution 116-5-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-5-20 TITLE: Recognition Resolution ACTION: PASS WHEREAS, the individuals listed here have made significant contributions to NABP, the protection of the public health, and the practice of pharmacy: James A. “Buddy” Bowden (AR) Lois Cantin (MB) John T. Douglas (AR) Rocco F. Giruzzi, Jr (NY) William A. “Bill” Gouveia (MA) Leonard L. Inge, […]

Read More ›

Task Force on Medication Reuse (Resolution 116-4-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-4-20 TITLE: Task Force on Medication Reuse ACTION: PASS WHEREAS, every year millions of dollars of costly, previously dispensed, or short-dated medications may be thrown away while some uninsured or indigent patients fail to receive lifesaving therapies they need; and WHEREAS, the Model State Pharmacy Act and Model Rules of the National Association […]

Read More ›

Incorporating Criminal Background Checks into the NABP e-Profile System (Resolution 116-3-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-3-20 TITLE: Incorporating Criminal Background Checks into the NABP e-Profile System ACTION: PASS WHEREAS, the NABP Clearinghouse is a vital tool for member state boards of pharmacy to assess licensure or registration of applicants and to monitor professional accountability; and WHEREAS, some member state boards of pharmacy require a criminal background check as […]

Read More ›

Development and Administration of Patient-Specific Biologics (Resolution 116-2-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-2-20 TITLE: Development and Administration of Patient-Specific Biologics ACTION: PASS WHEREAS, drug manufacturers often receive blood components from a patient for the development of a patient-specific biologic and the final formulation is shipped directly to a practitioner for administration to the patient; and WHEREAS, it is unclear whether shipping of this patient-specific biologic […]

Read More ›

State Pharmacy Boards’ Responses to FDA Form 483 Observations (Resolution 116-1-20)

Posted by

Icon of scale representing regulatory news

RESOLUTION NO: 116-1-20 TITLE: State Pharmacy Boards’ Responses to FDA Form 483 Observations ACTION: PASS WHEREAS, United States Food and Drug Administration (FDA) frequently conducts inspections of 503A pharmacies and can potentially issue an FDA Form 483, which documents the inspector’s observations and is not a citation or notice of violation of any law or […]

Read More ›

Delegates Approve Five Resolutions at the 116th NABP Annual Meeting

Posted by

Icon of scale representing regulatory news

Delegates from the member boards of pharmacy adopted five resolutions during the 116th National Association of Boards of Pharmacy® (NABP®) Annual Meeting, held virtually on May 14, 2020. The resolutions addressed the following: providing guidance to member boards of pharmacy regarding taking disciplinary action against a pharmacy license based solely on observations from Food and […]

Read More ›

NABP 2020-2021 Executive Committee Inaugurated at Association’s 116th Annual Meeting

Posted by

Icon of scale representing regulatory news

Delegates to the 116th National Association of Boards of Pharmacy® (NABP®) Annual Meeting, held virtually on May 14, 2020, elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2020-2021 Executive Committee. The newly elected officers of the NABP Executive Committee are President-elect Caroline D. Juran, BSPharm, DPh (Hon), executive director […]

Read More ›

NABP Announces 2020 Leaders at the Forefront of Public Health Protection

Posted by

Icon of scale representing regulatory news

The National Association of Boards of Pharmacy® (NABP®) has announced its leaders in the protection of public health for 2020. Each year, the Association presents awards to individuals who have worked with unwavering dedication to ensure NABP’s continued service to the regulation of pharmacy practice and its efforts to assist the state boards of pharmacy […]

Read More ›

2020 Report of the Executive Director

Posted by

Icon of scale representing regulatory news

Lemrey “Al” Carter, MS, PharmD, RPh, presented the Report of the Executive Director during the 116th Annual Meeting: “I would first like to take this opportunity to thank the National Association of Boards of Pharmacy® (NABP®) Executive Committee for their confidence and trust in me to lead this amazing organization; I am honored and humbled […]

Read More ›

2020 Report of the Incoming President

Posted by

Icon of scale representing regulatory news

Timothy D. Fensky, RPh, DPh, FACA, presented the Report of the Incoming President during the 116th Annual Meeting: “As I write this report, I find myself reflecting on the inspiring minds and talents that make up the NABP membership. I feel confident that united as one, we are ready to take off on a new […]

Read More ›
Page 4 of 23
1 2 3 4 5 6 23